Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: A candidate-gene association study

Journal of Human Genetics

Volumn 54, Issue 11, 2009, Pages 655-659

  Mollaki, Vassiliki ^a   Georgiadis, Thomas ^b   Tassidou, Anna ^c   Ioannou, Maria ^d   Daniil, Zoe ^d   Koutsokera, Aggeliki ^d   Papathanassiou, Aphrodite A ^d   Zintzaras, Elias ^d,e   Vassilopoulos, George ^a,d  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b HYGEIA HOSPITAL   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene; HL; Hodgkins lymphoma; MYD88; Polymorphism; TLR9

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 9;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HAPLOTYPE; HETEROZYGOTE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE;

ADULT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HODGKIN DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MYELOID DIFFERENTIATION FACTOR 88; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 74049146800     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2009.90     Document Type: Article

References (33)

1. Ries, L. A. G., Harkins, D., Krapcho, M., Mariotto, A., Miller, B. A., Feuer, E. J. et al. SEER Cancer Statistics Review, 1975-2005 (National Cancer Institute, Bethesda, MD, 2006) (http://seer.cancer.gov/statfacts/html/hodg.html) .
2. Cartwright, R. A. & Watkins, G. Epidemiology of Hodgkin's disease: a review. Hematol. Oncol. 22, 11-26 (2004).
3. Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W. et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest 100, 2961-2969 (1997).
4. Serraino, D., Franceschi, S., Talamini, R., Barra, S., Negri, E., Carbone, A. et al. Socioeconomic indicators, infectious diseases and Hodgkin's disease. Int. J. Cancer 47, 352-357 (1991).
5. Levine, R., Zhu, K., Gu, Y., Brann, E., Hall, I., Caplan, L. et al. Self-reported infectious mononucleosis and 6 cancers: a population-based, case-control study. Scand J. Infect. Dis. 30, 211-214 (1998).
6. Hjalgrim, H., Askling, J., Sorensen, P., Madsen, M., Rosdahl, N., Storm, H. H. et al. Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J. Natl Cancer Inst. 92, 1522-1528 (2000).
7. Alexander, F. E., Daniel, C. P., Armstrong, A. A., Clark, D. A., Onions, D. E., Cartwright, R. A. et al. Gene clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin's disease: results of a case-control study. Eur. J. Cancer 31A, 1479-1486 (1995).
8. Grässer, F. A., Murray, P. G., Kremmer, E., Klein, K., Remberger, K., Feiden, W. et al. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 84, 3792-3798 (1994).
9. Gallagher, A., Armstrong, A. A., MacKenzie, J., Shield, L., Khan, G., Lake, A. et al. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBVassociated Hodgkin's disease. Int. J. Cancer 84, 442-448 (1999).
10. Hiscott, J., Kwon, H. & Genin, P. Hostile takeovers: viral appropriation of the NFkappaB pathway. J. Clin. Invest 107, 143-151 (2001).
11. Goldgar, D. E., Easton, D. F., Cannon-Albright, L. A. & Skolnick, M. H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl Cancer Inst. 86, 1600-1608 (1994).
12. Westergaard, T., Melbye, M., Pedersen, J. B., Frisch, M., Olsen, J. H. & Andersen, P. K. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int. J. Cancer 72, 977-981 (1997).
13. Paltiel, O., Schmit, T., Adler, B., Rachmilevitz, E. A., Polliack, A., Cohen, A. et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study. Cancer 88, 2357-2366 (2000).
14. Shugart, Y. Y., Hemminki, K., Vaittinen, P., Kingman, A. & Dong, C. A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden. Hum. Genet. 106, 553-556 (2000).
15. Goldin, L. R., Pfeiffer, R. M., Gridley, G., Gail, M. H., Li, X., Mellemkjaer, L. et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 100, 1902-1908 (2004).
16. Mack, T. M., Cozen, W., Shibata, D. K., Weiss, L. M., Nathwani, B. N., Hernandez, A. M. et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N. Engl. J. Med. 332, 413-418 (1995).
17. Parker, L. C., Prince, L. R. & Sabroe, I. Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin. Exp. Immunol. 147, 199-207 (2007).
18. Bowie, A. G. & Haga, I. R. The role of Toll-like receptors in the host response to viruses. Mol. Immunol. 42, 859-867 (2005).
19. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H. et al. Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
20. Nieters, A., Beckmann, L., Deeg, E. & Becker, N. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun. 7, 615-624 (2006).
21. Du, X., Poltorak, A., Wei, Y. & Beutler, B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 11, 362-371 (2000).
22. Lazarus, R., Klimecki, W. T., Raby, B. A., Vercelli, D., Palmer, L. J., Kwiatkowski, D. J. et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 81, 85-91 (2003).
23. Bonnert, T. P., Garka, K. E., Parnet, P., Sonoda, G., Testa, J. R. & Sims, J. E. The cloning and characterization of human MyD88: a member of an IL-1 receptor related family. FEBS Lett. 402, 81-84 (1997).
24. Lazarus, R., Vercelli, D., Palmer, L. J., Klimecki, W. J., Silverman, E. K., Richter, B. et al. Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol. Rev. 190, 9-25 (2002).
25. Lewis, P. O. & Zaykin, D. Genetic Data Analysis: computer program for the analysis of allelic data release 1.0 (2001).
26. Weir, B. S. Genetic Data Analysis II (Sinauer Associates, Inc, Sunderland, MA, USA, 1996).
27. Baker, R. J. GLIM 3.77 Reference Manual (Numerical Algorithms Group Ltd, Oxford, UK, 1987).
28. Zintzaras, E. & Lau, J. Synthesis of genetic association studies for pertinent genedisease associations requires appropriate methodological and statistical approaches. J. Clin. Epidemiol. 61, 634-645 (2008).
29. Zintzaras, E., Kitsios, G. D., Triposkiadis, F., Lau, J. & Raman, G. APOE gene polymorphisms and response to statin therapy. Pharmacogenomics J. 4, 248-257 (2009).
30. Takeshita, F., Suzuki, K., Sasaki, S., Ishii, N., Klinman, D. M. & Ishii, K. J. Transcriptional regulation of the human TLR9 gene. J. Immunol. 173, 2552-2561 (2004).
31. Hasan, U. A., Bates, E., Takeshita, F., Biliato, A., Accardi, R., Bouvard, V. et al. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J. Immunol. 178, 3186-3197 (2007).
32. Hamann, L., Glaeser, C., Hamprecht, A., Gross, M., Gomma, A. & Schumann, R. R. Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin. Chim. Acta. 364, 303-307 (2006).
33. Novak, N., Yu, C. F., Bussmann, C., Maintz, L., Peng, W. M., Hart, J. et al. Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 62, 766-772 (2007).